v3.26.1
Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Accumulated Other Comprehensive (Loss)/Income [Member]
Beginning balance at Dec. 31, 2024 $ 352,477 $ 31 $ 526,732 $ (174,392) $ 106
Beginning balance, shares at Dec. 31, 2024   31,115,341      
Exercised of pre-funded warrants 1 $ 1      
Exercised of pre-funded warrants, Shares   1,000,333      
Exercise of stock options 31 $ 0 31    
Exercise of stock options, shares   3,321      
Issuance of common stock under employee stock purchase plan 129   129    
Issuance of common stock under employee stock purchase plan (in shares)   6,938      
Stock-based compensation expense 5,315   5,315    
Net loss (29,511)     (29,511)  
Unrealized gain (loss) on marketable securities 164       164
Ending balance at Mar. 31, 2025 328,606 $ 32 532,207 (203,903) 270
Ending balance, shares at Mar. 31, 2025   32,125,933      
Beginning balance at Dec. 31, 2024 352,477 $ 31 526,732 (174,392) 106
Beginning balance, shares at Dec. 31, 2024   31,115,341      
Net loss (61,140)        
Unrealized gain (loss) on marketable securities (8)        
Ending balance at Jun. 30, 2025 303,079 $ 32 538,481 (235,532) 98
Ending balance, shares at Jun. 30, 2025   32,176,482      
Beginning balance at Mar. 31, 2025 328,606 $ 32 532,207 (203,903) 270
Beginning balance, shares at Mar. 31, 2025   32,125,933      
Exercise of stock options 568   568    
Exercise of stock options, shares   50,549      
Stock-based compensation expense 5,706   5,706    
Net loss (31,629)     (31,629)  
Unrealized gain (loss) on marketable securities (172)       (172)
Ending balance at Jun. 30, 2025 303,079 $ 32 538,481 (235,532) 98
Ending balance, shares at Jun. 30, 2025   32,176,482      
Beginning balance at Dec. 31, 2025 493,401 $ 43 829,598 (336,729) 489
Beginning balance, shares at Dec. 31, 2025   43,223,090      
Issuance of common stock and pre-funded warrants in connection with public offering, net of issuance costs 676,080 $ 8 676,072    
Issuance of common stock and pre-funded warrants in connection with public offering, net of issuance costs, shares   8,470,989      
Issuance of common stock pursuant to at-the-market offering, net of issuance costs,Shares   1,123,126      
Issuance of common stock pursuant to at-the-market offering, net of issuance costs 58,731 $ 1 58,730    
Exercise Of Warrants And Pre-funded Warrants 1 $ 1      
Exercise Of Warrants And Pre-Funded Warrants Shares   1,004,580      
Exercise of stock options 4,277 $ 1 4,276    
Exercise of stock options, shares   753,075      
Issuance of common stock under employee stock purchase plan 120   120    
Issuance of common stock under employee stock purchase plan (in shares)   7,889      
Stock-based compensation expense 10,602   10,602    
Net loss (40,834)     (40,834)  
Unrealized gain (loss) on marketable securities (1,064)       (1,064)
Ending balance at Mar. 31, 2026 1,201,314 $ 54 1,579,398 (377,563) (575)
Ending balance, shares at Mar. 31, 2026   54,582,749      
Beginning balance at Dec. 31, 2025 $ 493,401 $ 43 829,598 (336,729) 489
Beginning balance, shares at Dec. 31, 2025   43,223,090      
Exercise of stock options, shares 968,664        
Net loss $ (91,049)        
Unrealized gain (loss) on marketable securities (2,617)        
Ending balance at Jun. 30, 2026 1,172,025 $ 55 1,601,876 (427,778) (2,128)
Ending balance, shares at Jun. 30, 2026   54,798,338      
Beginning balance at Mar. 31, 2026 1,201,314 $ 54 1,579,398 (377,563) (575)
Beginning balance, shares at Mar. 31, 2026   54,582,749      
Exercise of stock options 10,581 $ 1 10,580    
Exercise of stock options, shares   215,589      
Stock-based compensation expense 11,898   11,898    
Net loss (50,215)     (50,215)  
Unrealized gain (loss) on marketable securities (1,553)       (1,553)
Ending balance at Jun. 30, 2026 $ 1,172,025 $ 55 $ 1,601,876 $ (427,778) $ (2,128)
Ending balance, shares at Jun. 30, 2026   54,798,338